GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level

2 weeks ago 21

Apothecary Pharma LLC. issued a voluntary recall of nearly two dozen lots of Tirzepatide injections due to sterility concerns, with the FDA classifying the risk as Class II — low but not obsolete.

A nationwide recall is being issued for the active ingredient behind mega-popular GLP-1 medications, Mounjaro and Zepbound.

Read Entire Article